FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Riluzole Oral Suspension
Status: Currently in Shortage
»Date first posted: 01/26/2024
»Therapeutic Categories: Neurology

Expand all

EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) (Reverified 04/16/2024)

Company Contact Information:
610-937-6172

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-2)	Unavailable	Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to viscosity testing	Requirements related to complying with good manufacturing practices
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)	Available	Dear Healthcare Provider Letter: Temporary importation granted to mitigate the current shortage of FDA-approved Tiglutik (HYPERLINK)
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)	Available	Dear Healthcare Provider Letter: Temporary importation granted to mitigate the current shortage of FDA-approved Tiglutik (HYPERLINK)